ArticleScience advances2020
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms.
Mark Borris D Aldonza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it